CUREVO
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines that brings effectiveness, safety, tolerability, and advanced production capabilities to the market. Curevo's lead product, a sub-unit Zoster (Shingles) Vaccine, has completed Phase I (90 subject trial). Results are showing a promising safety profile and the desired immune responses. They are targeting a unique position in the $7B Varicella Zoster Virus vaccine market.
CUREVO
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Website Url:
http://www.curevovaccine.com
Total Employee:
1+
Status:
Active
Contact:
1(206)492-5722
Total Funding:
60 M USD
Technology used in webpage:
Domain Not Resolving Microsoft Exchange Online
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Current Employees Featured
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series A - Curevo
E&Investment
E&Investment investment in Series A - Curevo
RA Capital Management
RA Capital Management investment in Series A - Curevo
Green Cross Holding Corp
Green Cross Holding Corp investment in Series A - Curevo
Adjuvant Capital
Adjuvant Capital investment in Series A - Curevo
Official Site Inspections
http://www.curevovaccine.com
- Host name: 192.0.78.148
- IP address: 192.0.78.148
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Curevo"
Home - Curevo Vaccine
Focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical โฆSee details»
Curevo - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 1(206)492-5722 Curevo is a clinical-stage biotech firm focused on producing vaccines that brings effectiveness, safety, tolerability, and advanced production capabilities to the โฆSee details»
Management Team - Curevo Vaccine
Executive Team Board of Directors Scientific Advisors Executive Team Linkedin George Simeon CEO & Board Director George Simeon is the CEO of Curevo Vaccine. He joined Curevo at โฆSee details»
Curevo Vaccine - LinkedIn
Curevo Vaccine Biotechnology Research Bothell, Washington 2,034 followers Seattle-based clinical-stage biotech company with a lead product CRV-101, a sub-unit vaccine for the โฆSee details»
Curevo Vaccine Company Profile 2024: Valuation, โฆ
Curevo Vaccine General Information Description. Developer of a clinical-stage adjuvanted subunit vaccine intended to improve efficacy and broaden immune response. The company leverages its proprietary platform to design and โฆSee details»
Curevo Vaccine Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.curevovaccine.com. โฆSee details»
Curevo Vaccine Overview - Salary.com
Discover essential details about Curevo Vaccine, including address, contact, and journey of our company's evolution.See details»
Curevo Vaccine - htgc.com
Curevo Vaccine is a privately held, clinical-stage biotechnology company based near Seattle and dedicated to reducing the burden of infectious disease by developing safe and highly effective โฆSee details»
Curevo Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Our History - Curevo Vaccine
Our Mission Safety. Supply. Efficacy. By combining excellence in protein and adjuvant biology, we are focused on creating a new generation of adjuvanted subunit vaccines of global โฆSee details»
Curevo Presents Positive Shingles Vaccine Outcomes Data
Oct 31, 2024 Contacts David Miller Sr. Director of Strategic Communications [email protected] More in Markets View All. Fidelityโs Jurrien Timmer on Why the Stock โฆSee details»
P4VE Funded Partners | P4VE | CDC - Centers for Disease Control โฆ
Jun 21, 2024 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock ( ) or https:// means you've safely connected to the โฆSee details»
Curevo, Inc. - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆๆฐ่ฏ โฆ
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune response non-inferior to Shingrix, โฆSee details»
Curevo Vaccine Announces Enrollment Complete in Phase 2b Trial โฆ
Sep 15, 2022 -- Phase 2b trial enrolled 678 participants in six months-- Topline data from Phase 2b head-to-head trial of CRVโ101 against Shingrix® expected in early 2023. SEATTLE, Sept. โฆSee details»
GC Pharma to Establish Curevo - Curevo Vaccine
May 18, 2018 As a non-profit global research organization, MIBR (Mogam Institute for Biomedical Research) is engaged in basic drug discovery research to combat infectious โฆSee details»
Cision PR Newswire - NBC4 WCMH-TV
Sep 15, 2022 -- Phase 2b trial enrolled 678 participants in six months -- Topline data from Phase 2b head-to-head trial of CRVโ101 against Shingrix® expected in early 2023 SEATTLE, Sept. โฆSee details»
Curevo Presents Positive Shingles Vaccine Outcomes Data
Oct 31, 2024 โ Updated data will be featured in an oral presentation at the World Vaccine Congress Barcelona, 31 October 2024, in Theatre 5 at 13:30 CEST . SEATTLE, Oct. 31, 2024 โฆSee details»
Partnerships - Curevo Vaccine
Through our strategic partnership, we can leverage broader expertise and a global perspective. By partnering with GC Pharma and Mogam Biomedical Research Institute, we focus on โฆSee details»
How much do Curevo Vaccine employees make? | Salary.com
The average annual salary of Curevo Vaccine is estimated to be approximate $101,335 per year. The majority pay is between $89,271 to $114,440 per year. Visit Salary.com to find out Curevo โฆSee details»
Careers - Curevo Vaccine
Curevo is a proud Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability โฆSee details»